Abstrax and AVD Advance Inhalation Safety for the Cannabis Industry
Summary
Abstraxs comprehensive Risk Assessment and Toxicological Evaluation Program (RA-TEP) is being developed with guidance from McKinney Regulatory Science Advisors, LLC, and is modeled after FDA testing guidelines for similarly used consumer products. The RA-TEP addresses a more comprehensive range of risks and hazards than the Continuous Materials Review (CMR) approach used by other vape hardware and terpene suppliers because of a known cannabis industry knowledge gap. Abstrax Labs offers cutting-edge R&D, extraction and analytical technologies through its proprietary Terplytics™ system, a sensory quantification software application, which yielded the worlds most comprehensive cannabis cultivar phytochemical database. Decades of experience working with the cannabis plant inform AVDs personalized solutions for their Client Partners based on a deep understanding of the nuanced interplay between extraction methods, formulation, absorption, heating and vaporization delivery. Our core values — Persistent Excellence, Collaborative Trust, Advocate for Empowerment, Foster Transparency, Inspire Confidence, and Empower with Knowledge — serve as the pillars of our approach and operations.